tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Avalo Therapeutics initiated with an Outperform at Mizuho
PremiumThe FlyAvalo Therapeutics initiated with an Outperform at Mizuho
1M ago
Avalo Completes Enrollment for Phase 2 LOTUS Trial
Premium
Company Announcements
Avalo Completes Enrollment for Phase 2 LOTUS Trial
2M ago
Avalo Therapeutics Reports Q3 2025 Financial Results
Premium
Company Announcements
Avalo Therapeutics Reports Q3 2025 Financial Results
3M ago
Oppenheimer healthcare analysts hold an analyst/industry conference call
PremiumThe FlyOppenheimer healthcare analysts hold an analyst/industry conference call
3M ago
Avalo Therapeutics management to meet with Piper Sandler
Premium
The Fly
Avalo Therapeutics management to meet with Piper Sandler
4M ago
Avalo Therapeutics Highlights AVTX-009 Potential in New Presentation
Premium
Company Announcements
Avalo Therapeutics Highlights AVTX-009 Potential in New Presentation
4M ago
Avalo Therapeutics price target raised to $25 from $15 at H.C. Wainwright
PremiumThe FlyAvalo Therapeutics price target raised to $25 from $15 at H.C. Wainwright
4M ago
Oppenheimer buyers of Avalo Therapeutics ahead of lutikizumab data
Premium
The Fly
Oppenheimer buyers of Avalo Therapeutics ahead of lutikizumab data
5M ago
3 Best Stocks to Buy Now, 9/12/2025, According to Top Analysts
Premium
Market News
3 Best Stocks to Buy Now, 9/12/2025, According to Top Analysts
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100